Compare
Compare archived captures
This view highlights text differences between two archived captures. It does not interpret meaning or provide guidance.
Descriptive changes only
This comparison highlights text changes between archived captures. It does not interpret the change or provide medical advice. For up-to-date recommendations, always consult the official source website.
Need to cite this comparison? See /cite.
Earlier capture
Archived 47: Summary of National Advisory Committee on Immunization (NACI) updates of November 3, 2022: Recommendations on the use of Moderna Spikevax BA.4/5 bivalent mRNA (50 mcg) COVID-19 booster vaccine in adults - Canada.ca
Apr 18, 2025
legacy-hc-2025-04-21
ID 210615
Later capture
Archived 47: Summary of National Advisory Committee on Immunization (NACI) updates of November 3, 2022: Recommendations on the use of Moderna Spikevax BA.4/5 bivalent mRNA (50 mcg) COVID-19 booster vaccine in adults - Canada.ca
Apr 18, 2025
legacy-hc-2025-04-21
ID 140576
updatedArchived text updated
0 sections changed0 added0 removed+0 / -0 linesChange ratio: 0%
No diff is available for this capture pair. This can happen when content is unchanged or stored in a non-HTML format.